首页> 外文期刊>Human Genetics >Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.
【24h】

Identification and experimental validation of G protein alpha inhibiting activity polypeptide 2 (GNAI2) as a microRNA-138 target in tongue squamous cell carcinoma.

机译:鉴定和实验验证G蛋白α抑制活性多肽2(GNAI2)作为舌鳞状细胞癌中的microRNA-138靶标。

获取原文
获取原文并翻译 | 示例
       

摘要

MicroRNA deregulation is a critical event in tumor initiation and progression. The down-regulation of microRNA-138 has been frequently observed in various cancers, including tongue squamous cell carcinoma (TSCC). Our previous studies suggest that deregulation of miR-138 is associated with the enhanced proliferation and invasion in TSCC cells. Here, we seek to identify the targets of miR-138 in TSCC, and explore their functional relevance in tumorigenesis. Our genome-wide expression profiling experiments identified a panel of 194 unique transcripts that were significantly down-regulated in TSCC cells transfected with miR-138. A comprehensive screening using six different sequence-based microRNA target prediction algorithms revealed that 51 out of these 194 down-regulated transcripts are potential direct targets for miR-138. These targets include: chloride channel, nucleotide-sensitive, 1A (CLNS1A), G protein alpha inhibiting activity polypeptide 2 (GNAI2), solute carrier family 20, member 1 (SLC20A1), eukaryotic translation initiation factor 4E binding protein 1 (EIF4EBP1), and Rho-related GTP-binding protein C (RhoC). GNAI2 is a known proto-oncogene that is involved in the initiation and progression of several different types of tumors. Direct targeting of miR-138 to two candidate binding sequences located in the 3'-untranslated region of GNAI2 mRNA was confirmed using luciferase reporter gene assays. Knockdown of miR-138 in TSCC cells enhanced the expression of GNAI2 at both mRNA and protein levels. In contrast, ectopic transfection of miR-138 reduced the expression of GNAI2, which, in consequence, led to reduced proliferation, cell cycle arrest and apoptosis. In summary, we identified a number of high-confident miR-138 target genes, including proto-oncogene GNAI2, which may play an important role in TSCC initiation and progression.
机译:MicroRNA失调是肿瘤起始和进展中的关键事件。在包括舌鳞状细胞癌(TSCC)在内的各种癌症中经常观察到microRNA-138的下调。我们以前的研究表明,miR-138的失调与TSCC细胞中增殖和侵袭的增强有关。在这里,我们寻求确定miRNA-138在TSCC中的靶标,并探讨它们在肿瘤发生中的功能相关性。我们的全基因组表达谱分析实验确定了一组194个独特的转录本,这些转录本在用miR-138转染的TSCC细胞中显着下调。使用六种不同的基于序列的microRNA靶预测算法的全面筛选显示,这194种下调的转录物中有51种是miR-138的潜在直接靶标。这些靶标包括:氯离子通道,核苷酸敏感,1A(CLNS1A),G蛋白α抑制活性多肽2(GNAI2),溶质载体家族20,成员1(SLC20A1),真核翻译起始因子4E结合蛋白1(EIF4EBP1), Rho相关的GTP结合蛋白C(RhoC)。 GNAI2是已知的原癌基因,与几种不同类型的肿瘤的发生和发展有关。使用萤光素酶报告基因检测证实了miR-138直接靶向位于GNAI2 mRNA 3'-非翻译区的两个候选结合序列。敲低TSCC细胞中的miR-138可以在mRNA和蛋白质水平上增强GNAI2的表达。相反,miR-138的异位转染降低了GNAI2的表达,因此导致增殖,细胞周期停滞和凋亡减少。总而言之,我们鉴定了许多高度自信的miR-138靶基因,包括原癌基因GNAI2,它们可能在TSCC的启动和发展中发挥重要作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号